Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $75,796 - $102,668
-395 Reduced 22.01%
1,400 $282,000
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $148,226 - $188,052
-752 Reduced 29.52%
1,795 $390,000
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $9.85 Million - $13.5 Million
-53,981 Reduced 95.49%
2,547 $502,000
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $1.04 Million - $1.54 Million
-5,086 Reduced 8.25%
56,528 $12.1 Million
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $1.68 Million - $2.38 Million
-6,586 Reduced 9.66%
61,614 $17.5 Million
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $2.46 Million - $3.14 Million
-7,000 Reduced 9.31%
68,200 $25.7 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $5.97 Million - $7.34 Million
-16,013 Reduced 17.56%
75,200 $31 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $1.44 Million - $1.82 Million
4,899 Added 5.68%
91,213 $33.7 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $1.09 Million - $1.31 Million
4,370 Added 5.33%
86,314 $25 Million
Q4 2020

Feb 10, 2021

BUY
$222.0 - $252.62 $7.7 Million - $8.76 Million
34,684 Added 73.39%
81,944 $20.5 Million
Q3 2020

Nov 12, 2020

BUY
$175.56 - $226.45 $6.96 Million - $8.98 Million
39,655 Added 521.43%
47,260 $10.7 Million
Q2 2020

Aug 10, 2020

BUY
$118.84 - $189.72 $308,984 - $493,272
2,600 Added 51.95%
7,605 $1.33 Million
Q1 2020

May 11, 2020

BUY
$98.9 - $178.34 $494,994 - $892,591
5,005 New
5,005 $631,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.33B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.